Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Meihua International Medical Technologies | MHUA | Jan 17, 2025 | 0.32 | +3.31 |
MeiraGTx Holdings | MGTX | Jan 17, 2025 | 6.26 | +5.56 |
Meiwu Technology | WNW | Jan 17, 2025 | 0.37 | +19.32 |
Melar Acquisition I | MACIU | Jan 17, 2025 | 10.12 | 0.00 |
Melar Acquisition I | MACI | Jan 17, 2025 | 10.11 | +0.10 |
Melco Resorts & Entertainment ADR | MLCO | Jan 17, 2025 | 5.54 | +1.65 |
MercadoLibre | MELI | Jan 17, 2025 | 1 836.00 | -0.06 |
Mercantile Bank | MBWM | Jan 17, 2025 | 44.21 | +1.03 |
Mercer International | MERC | Jan 17, 2025 | 6.45 | +0.94 |
Merchants Bancorp | MBIN | Jan 17, 2025 | 38.67 | +2.03 |
Merchants Bancorp B | MBINO | Jan 17, 2025 | 25.00 | 0.00 |
Merchants Bancorp C Pref | MBINN | Jan 17, 2025 | 21.60 | +0.47 |
Merchants Bancorp Pref D | MBINM | Jan 17, 2025 | 26.40 | +1.03 |
Merck & Co | MRK | Jan 17, 2025 | 97.92 | -2.76 |
Mercurity Fintech | MFH | Jan 17, 2025 | 7.47 | +2.61 |
Mercury General | MCY | Jan 17, 2025 | 48.19 | -7.45 |
Mercury Systems | MRCY | Jan 17, 2025 | 42.92 | +0.14 |
Mereo BioPharma ADR | MREO | Jan 17, 2025 | 2.86 | -1.38 |
Meridian | MRBK | Jan 17, 2025 | 15.31 | +0.13 |
MeridianLink | MLNK | Jan 17, 2025 | 19.64 | +1.55 |
Merit Medical Systems | MMSI | Jan 17, 2025 | 102.90 | +0.81 |
Meritage Homes | MTH | Jan 17, 2025 | 80.58 | -0.22 |
Merrill Lynch & Co. | IPB | Jan 17, 2025 | 25.48 | +0.00 |
Mersana Therapeutics | MRSN | Jan 17, 2025 | 0.62 | +0.68 |
Merus N.V | MRUS | Jan 17, 2025 | 39.45 | -0.50 |
Mesa Air Group | MESA | Jan 17, 2025 | 1.33 | 0.00 |
Mesa Laboratories | MLAB | Jan 17, 2025 | 139.61 | +1.79 |
Mesa Royalty Trust | MTR | Jan 17, 2025 | 6.75 | -1.32 |
Mesabi Royalty Trust | MSB | Jan 17, 2025 | 28.92 | +0.80 |
Mesoblast ADR | MESO | Jan 17, 2025 | 17.30 | +3.78 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.